![]() Research in the laboratory of Buck faculty member Dr. Simon Melov ( Melov) and in furtherance of this objective Sponsor and Buck have entered into a Sponsored Research Agreement of even date herewith (the MelovĮ. Cenexys entered into a similar licensingĪnd funded research arrangement with the Mayo Foundation for Medical Education and Research ( Mayo), executing an Exclusive License Agreement with Mayo effective June 28, 2013, and a sponsored research agreement with MayoĮffective September 25, 2014 (the Mayo Research Agreement) Prior License Agreement inventions arising from such funded research.Ĭ. ![]() Buck and Cenexys have also previously entered into a Sponsored Research Agreement, effective as of August 21,Ģ014, pursuant to which Sponsor funded certain research conducted in the laboratory of Dr. Judith Campisi ( Campisi) at Buck (the Campisi Research Agreement) in exchange for an option to include within the Know-How (all as defined in the Prior License Agreement).ī. License Agreement dated February 3, 2014 (the Prior License Agreement) pursuant to which Buck granted to Cenexys an exclusive license to certain Patent Rights and ( Cenexys) and Buck previously entered into that certain This Amended and Restated License Agreement ( Agreement) is made as of the 27th day of January, 2017 (the Signatureĭate) by and between the Buck Institute for Research on Aging, a California non-profit public benefit corporation having its principal place of business at 8001 Redwood Boulevard, Novato, Californiaĩ4945 ( Buck), and Unity Biotechnology, Inc., a Delaware corporation, having a place of business at 3280 Brisbane Blvd, Brisbane, California 94005 ( Sponsor).Ī. ![]() ![]() Requested with respect to the omitted portions.ĪMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |